Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects
Status:
RECRUITING
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of SHR-3167 compared with insulin glargine after treatment in insulin nave subjects with type 2 diabetes treated with metformin alone or in combination with SGLT2 subjects.